- €1.40bn
- €3.34bn
- €5.67bn
Brief: Lanxess - Causeway Capital Management Trust Holds 15.1% Of Total Voting Rights Through Shares And Instruments In Lanxess As Of Nov 10 (Previously 10.08%)
Barclays is bearish on European Chemicals & Ingredients, warns of structural decline
Brief: Lanxess Extends Term With CFO Oliver Stratmann
Jefferies ups Lanxess citing improvement potential to operating performance
German chemicals lobby VCI says no sector turnaround in sight after weak Q3 (updated)
German chemicals lobby VCI says no sector turnaround in sight after weak Q3
Europe Research Roundup: Beijer Ref, DKSH Holding, Yara
Lanxess CEO sees gradual recovery for chemical industry in 2026
Lanxess shares fall in early trade on 'as bad as feared' Q3 results
Lanxess posts worse than expected Q3 sales and warns on FY profit (updated)
Brief: Lanxess Q3 Revenue Down 16.3% At EUR 1.34 Bln
Lanxess posts Q3 sales below expectations
Brief: Lanxess Q3 Sales EUR 1,340 Million Vs. Estimate EUR 1,434.9 Million
Europe Research Roundup: Atalaya Mining Copper, BNP Paribas, Tele2
Europe Research Roundup: Banijay Group, Maersk, Yellow Cake
Europe stocks slip; commodity, defence rallies offset by luxury losses (updated)
European shares fall as losses in financials, banks weigh
Chemicals maker Lanxess to sell its shares in Envalior in 2026 (updated)
Brief: Lanxess Exercises Right To Offer For The Sale Of Its Shares In Envalior In 2026